Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/106988
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Viperin is an important host restriction factor in control of Zika virus infection
Author: Van Der Hoek, K.
Eyre, N.
Shue, B.
Khantisitthiporn, O.
Glab-Ampi, K.
Carr, J.
Gartner, M.
Jolly, L.
Thomas, P.
Adikusuma, F.
Jankovic-Karasoulos, T.
Roberts, C.
Helbig, K.
Beard, M.
Citation: Scientific Reports, 2017; 7(1):4475 -1-4475-14
Publisher: Nature Publishing Group
Issue Date: 2017
ISSN: 2045-2322
2045-2322
Statement of
Responsibility: 
Kylie H. Van der Hoek, Nicholas S. Eyre, Byron Shue, Onruedee Khantisitthiporn, Kittirat Glab-Ampi, Jillian M. Carr, Matthew J. Gartner, Lachlan A. Jolly, Paul Q. Thomas, Fatwa Adikusuma, Tanja Jankovic-Karasoulos, Claire T. Roberts, Karla J. Helbig and Michael R. Beard
Abstract: Zika virus (ZIKV) infection has emerged as a global health threat and infection of pregnant women causes intrauterine growth restriction, spontaneous abortion and microcephaly in newborns. Here we show using biologically relevant cells of neural and placental origin that following ZIKV infection, there is attenuation of the cellular innate response characterised by reduced expression of IFN-β and associated interferon stimulated genes (ISGs). One such ISG is viperin that has well documented antiviral activity against a wide range of viruses. Expression of viperin in cultured cells resulted in significant impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin-/- mice replicated ZIKV to higher titers compared to their WT counterparts. These results suggest that ZIKV can attenuate ISG expression to avoid the cellular antiviral innate response, thus allowing the virus to replicate unchecked. Moreover, we have identified that the ISG viperin has significant anti-ZIKV activity. Further understanding of how ZIKV perturbs the ISG response and the molecular mechanisms utilised by viperin to suppress ZIKV replication will aid in our understanding of ZIKV biology, pathogenesis and possible design of novel antiviral strategies.
Keywords: Monocytes; Cell Line; Macrophages; Placenta; Animals; Mice, Knockout; Humans; Mice; Disease Models, Animal; Proteins; Virus Replication; Pregnancy; Female; Host-Pathogen Interactions; Immunity, Innate; Neural Stem Cells; CRISPR-Cas Systems; Zika Virus; Zika Virus Infection; Gene Editing
Description: Published online 30 June 2017
Rights: © The Author(s) 2017. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
RMID: 0030072063
DOI: 10.1038/s41598-017-04138-1
Grant ID: http://purl.org/au-research/grants/nhmrc/1053206
Appears in Collections:Paediatrics publications

Files in This Item:
File Description SizeFormat 
hdl_106988.pdfPublished Version5.38 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.